Prosecution Insights
Last updated: August 16, 2026

Meso Scale Technologies LLC

17 pending office actions • 12 art units • 16 examiners • 0 of 17 (0%) have an AI response strategy ready • 25 patents granted in the last 365 days

Portfolio Summary

17
Total Pending OAs
4
Non-Final OAs
12
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
4
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (4)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

13
Hard (76%)
3
Medium (18%)
0
Easy (0%)
1
Unknown (6%)

Rejection Statute Mix

BucketCases
§101 only2 (12%)
§101 + other4 (24%)
§103 only2 (12%)
Double-patenting + other1 (6%)
Multi-statute (no §101)7 (41%)
No statute on record1 (6%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
94% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
6% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

170 h
Manual time on pending OAs
34 h
Time saved (low, 20%)
59 h
Time saved (mid, 35%)
1.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GODDARD, LAURA B 2 51.0% +14.0%
OGUNTADE, ELIZABETH BISOLA 1 0.0% +0.0%
CHESTNUT, BARRY A 1 73.4% +6.3%
CHEU, CHANGHWA J 1 74.6% +47.4%
KIDWELL, KAITLYN ELIZABETH 1 77.1% +20.8%
YU, TIAN NMN 1 55.3% +18.7%
WANG, RUIXUE 1 57.4% +22.1%
HAVLIN, ROBERT H 1 51.6% +27.9%
EMCH, GREGORY S 1 48.8% +43.6%
LI, BAO Q 1 75.5% +26.4%

Hard Cases (13)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18145735 COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS YU, TIAN NMN 22d overdue
17494155 ANTIBODY ARRAY FOR MEASURING A PANEL OF AMYLOIDS LAFAVE, ELIZABETH ROSE 4d overdue
17607731 KITS FOR DETECTING ONE OR MORE TARGET NUCLEIC ACID ANALYTES IN A SAMPLE AND METHODS OF MAKING AND USING THE SAME GOLDBERG, JEANINE ANNE 19d
17890782 DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS HAVLIN, ROBERT H 27d
18118432 DIAGNOSTIC METHODS FOR LIVER DISORDERS CHEU, CHANGHWA J 29d
18473064 ORTHOPOXVIRUS SEROLOGY ASSAYS CHESTNUT, BARRY A 41d
17667714 BIOMARKERS OF THERAPEUTIC RESPONSIVENESS GODDARD, LAURA B 72d
18376575 LUNG CANCER BIOMARKERS OGUNTADE, ELIZABETH BISOLA

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18145735 COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS YU, TIAN NMN 22d overdue
17749716 ASSAYS FOR VIRAL STRAIN DETERMINATION LI, BAO Q 14d
17890782 DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS HAVLIN, ROBERT H 27d
18118432 DIAGNOSTIC METHODS FOR LIVER DISORDERS CHEU, CHANGHWA J 29d
17667714 BIOMARKERS OF THERAPEUTIC RESPONSIVENESS GODDARD, LAURA B 72d
18172941 METHODS AND DEVICES FOR INCREASING DYNAMIC RANGE OF OPTICAL SENSOR BASED SYSTEMS KIDWELL, KAITLYN ELIZABETH
17997267 VIRAL SEROLOGY ACE2 COMPETITION ASSAYS WANG, RUIXUE
17779900 METHODS AND KITS FOR DETECTING AUTOIMMUNE DISEASES EMCH, GREGORY S

Top Art Units

Art UnitApps
1678 4
1672 2
1642 2
1600 1
2800 1
1681 1
1626 1
1671 1
1798 1
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18376575 LUNG CANCER BIOMARKERS OGUNTADE, ELIZABETH BISOLA 1600 §101 Final Rejection Pending Oct 04, 2023
18473064 ORTHOPOXVIRUS SEROLOGY ASSAYS CHESTNUT, BARRY A 1672 §102§103§112 Non-Final OA 41d Pending Sep 22, 2023
18118432 DIAGNOSTIC METHODS FOR LIVER DISORDERS CHEU, CHANGHWA J 1678 §103§112 Final Rejection 29d Pending Mar 07, 2023
18172941 METHODS AND DEVICES FOR INCREASING DYNAMIC RANGE OF OPTICAL SENSOR BASED SYSTEMS KIDWELL, KAITLYN ELIZABETH 2800 §102§103§112 Final Rejection Pending Feb 22, 2023
18145735 COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS YU, TIAN NMN 1681 §103§112 Non-Final OA 22d overdue Pending Dec 22, 2022
17997267 VIRAL SEROLOGY ACE2 COMPETITION ASSAYS WANG, RUIXUE 1672 §103§112 Final Rejection Pending Oct 27, 2022
17890782 DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS HAVLIN, ROBERT H 1626 §103§112 Final Rejection 27d Pending Aug 18, 2022
17779900 METHODS AND KITS FOR DETECTING AUTOIMMUNE DISEASES EMCH, GREGORY S 1678 §103§112 Non-Final OA Pending May 25, 2022
17749716 ASSAYS FOR VIRAL STRAIN DETERMINATION LI, BAO Q 1671 Other Final Rejection 14d Pending May 20, 2022
17773896 METHODS AND KITS FOR QUANTITATING RADIATION EXPOSURE COUNTS, GARY W 1678 §101§103 Final Rejection Pending May 03, 2022
17728292 MULTI-PLEX ASSAY PLATES AND METHODS OF MAKING IVICH, FERNANDO NMN 1678 §103 Final Rejection Pending Apr 25, 2022
17686900 PACKAGING FOR ASSAYS AND RELATED METHODS KASS, BENJAMIN JOSEPH 1798 §103 Final Rejection Pending Mar 04, 2022
17667714 BIOMARKERS OF THERAPEUTIC RESPONSIVENESS GODDARD, LAURA B 1642 §101 Final Rejection 72d Pending Feb 09, 2022
17607731 KITS FOR DETECTING ONE OR MORE TARGET NUCLEIC ACID ANALYTES IN A SAMPLE AND METHODS OF MAKING AND USING THE SAME GOLDBERG, JEANINE ANNE 1682 §101§102Other Final Rejection 19d Pending Oct 29, 2021
17494155 ANTIBODY ARRAY FOR MEASURING A PANEL OF AMYLOIDS LAFAVE, ELIZABETH ROSE 1684 §101§103§112 Final Rejection 4d overdue Pending Oct 05, 2021
17394512 BIOMARKERS OF THERAPEUTIC RESPONSIVENESS GODDARD, LAURA B 1642 §101§103 Non-Final OA Pending Aug 05, 2021
17378294 ASSAY MODULES HAVING ASSAY REAGENTS AND METHODS OF MAKING AND USING SAME CHIN, CHRISTOPHER L 1677 §112DP Non-Final OA Pending Jul 16, 2021

Managing Meso Scale Technologies LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month